Fiasp Now Approved HCP Website

Brand: Fiasp (insulin aspart), Injection
Parent Company: Novo Nordisk
Drug Type: Prescription
Drug Category: Endocrinology
Campaign: now-approved
Targeting: HCPs
Patient Website: https://www.myfiasp.com/
HCP Website: https://www.fiasppro.com